| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |